125 matches for your search in the start-up spotlight
rss
Novel spectral filters will enable future sensors to work more accurately and reliably
30-Apr-2025
A research team from the University of Cologne has secured 1.1 million euros for the PoLightFilters start-up project from the EXIST-FT funding programme of the Federal Ministry for Economic Affairs and Climate Action (BMWK). With the development of a fundamentally novel technology for light ...
Shorten research and development time for cancer drugs from 3 years to 12 months and significantly reduce development costs
24-Mar-2025
The German-Swiss biotechnology start-up BioCopy has secured new capital of 8 million euros. This sum is an important step for the company on its mission to produce more effective cancer drugs in the shortest possible time and at significantly lower costs. The company is supported by a group of ...
Vaccine specialist secures financing of 1.6 million euros
27-Feb-2025
The veterinary vaccine developer VEROVACCiNES announces the successful comple tion of a €1.6 million financing round. The round was largely supported by existing investors as well as the founders. This underlines the joint confidence in the innovative strength and strategic direction of the ...
Investment led by Boehringer Ingelheim Venture Fund, with the participation of new and existing investors, including Apollo Health Ventures, NRW.Venture, and HTGF
09-Dec-2024
Refoxy Pharmaceuticals GmbH is a preclinical biotech company developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases. The company announced a €9.1 million seed-extension financing led by Boehringer Ingelheim Venture Fund (BIVF), and joined ...
"We help people lose weight. Without surgery, without implants, without lifelong medication"
19-Nov-2024
The German medical technology start-up Sedivention has received €800,000 in pre-seed funding from HTGF, one of the leading and most active early-stage investors in Germany and Europe. The Straßlach-based company is developing a medical device that enables a one-time, interventional, and minimally ...
University of Basel spin-off Translation-X receives Venture Kick funding
08-Oct-2024
In 2022, Dr. Özgür Genç together with Professor Peter Scheiffele from the Biozentrum, University of Basel, founded the startup Translation-X with the goal of developing novel therapeutics for autism spectrum disorders. They have now received 150’000 Swiss Francs investment from the Venture Kick ...
Swiss start-up NXI Therapeutics extends pre-seed financing to CHF 3.5 million in run-up to larger seed financing
25-Jun-2024
NXI Therapeutics AG, developer of tomorrow’s disruptive immunotherapies by coronin 1 modulation, announces the extension of a pre-Seed financing totalling to 3.5 million CHF. This financing extension comes in the run-up to a larger Seed financing that the company is currently raising. Kickfund ...
Enveda Biosciences announces $55M in new funding to accelerate platform and advance multiple candidates to clinical trials
19-Jun-2024
Enveda Biosciences announced a new financing round of $55 million to add to its $119 million combined Series B and B1. New investors Premji Invest, Lingotto Investment Fund, Microsoft, and The Nature Conservancy participated in the round alongside existing investors Kinnevik, True Ventures, FPV, ...
Funding for company’s SeaBeEYE project will be used to develop new therapeutic approach for geographic atrophy – advanced form of dry AMD
29-Apr-2024
SeaBeLife, a biotechnology company developing drug candidates intended to block cellular necrosis, announces the award of more than €1.5M ($1.6M) in financing for its SeaBeEYE project at the i-Nov 2024 innovation competition. Funded by the French government’s France 2030 investment plan and ...
Start-up Isospec Analytics raises $1.9m
18-Apr-2024
When developing new drugs, nutritional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to failed regulatory processes, or worse, consumer health being put in danger. ...
